News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Results> RemeGen (06938.HK) Full-Year Loss Expands to RMB278 Million
RemeGen-B (06938.HK) announced its 2025 annual results, with revenue recorded at RMB149 million, representing a year-on-year increase of 4.1%. The loss expanded from RMB270 million...
Reset
Send
The window will close in 5 seconds
<Results> RemeGen (06938.HK) Full-Year Loss Expands to RMB278 Million
Close
Recommend
1
Positive
1
Negative
6
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

RemeGen-B (06938.HK)  +0.350 (+0.544%)   announced its 2025 annual results, with revenue recorded at RMB149 million, representing a year-on-year increase of 4.1%. The loss expanded from RMB270 million in the previous year to RMB278 million, with a loss per share of RMB2.11. No dividend will be distributed. (de/d)(HK stocks quote is delayed for at least 15 mins.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.